Biohit Oyj (HEL:BIOBV)
Finland flag Finland · Delayed Price · Currency is EUR
2.480
+0.010 (0.40%)
Feb 25, 2026, 6:29 PM EET

Biohit Oyj Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15.714.2813.0810.959.36
Revenue Growth (YoY)
9.92%9.23%19.41%16.98%31.42%
Cost of Revenue
4.94.944.613.843.45
Gross Profit
10.89.348.467.115.92
Selling, General & Admin
4.244.093.633.45
Other Operating Expenses
2.92.442.191.871.98
Operating Expenses
7.66.786.645.987.42
Operating Income
3.22.561.831.13-1.5
Interest Expense
-0.1----
Interest & Investment Income
0.1----
Currency Exchange Gain (Loss)
--0.03-0.010.02
Other Non Operating Income (Expenses)
-0.10.560.41-0.290.09
EBT Excluding Unusual Items
3.13.122.260.83-1.39
Gain (Loss) on Sale of Investments
--0.25-0.070.040.06
Gain (Loss) on Sale of Assets
----0.02
Asset Writedown
-0.2----
Pretax Income
2.92.872.20.87-1.31
Income Tax Expense
0.20.30.340.270.2
Net Income
2.72.571.850.6-1.5
Net Income to Common
2.72.571.850.6-1.5
Net Income Growth
5.14%38.74%207.99%--
Shares Outstanding (Basic)
1515151515
Shares Outstanding (Diluted)
1515151515
Shares Change (YoY)
-0.18%0.58%0.41%0.13%-
EPS (Basic)
0.180.170.120.04-0.10
EPS (Diluted)
0.180.170.120.04-0.10
EPS Growth
4.96%41.15%200.41%--
Free Cash Flow
-1.30.180.651.79-0.48
Free Cash Flow Per Share
-0.090.010.040.12-0.03
Gross Margin
68.79%65.39%64.73%64.94%63.19%
Operating Margin
20.38%17.90%13.96%10.30%-16.02%
Profit Margin
17.20%17.98%14.16%5.49%-16.02%
Free Cash Flow Margin
-8.28%1.29%5.00%16.34%-5.10%
EBITDA
3.72.621.931.340.23
EBITDA Margin
23.57%18.34%14.78%12.24%2.46%
D&A For EBITDA
0.50.060.110.211.73
EBIT
3.22.561.831.13-1.5
EBIT Margin
20.38%17.90%13.96%10.30%-16.02%
Effective Tax Rate
6.90%10.43%15.67%30.76%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.